{"name":"Barbara Ensoli, MD","slug":"barbara-ensoli-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tat","genericName":"Tat","slug":"tat","indication":"HIV infection (therapeutic vaccine in combination with antiretroviral therapy)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Tat protein","genericName":"Tat protein","slug":"tat-protein","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Tat","genericName":"Tat","slug":"tat","phase":"marketed","mechanism":"Tat is a therapeutic vaccine based on the HIV Tat protein designed to boost immune responses against HIV-infected cells.","indications":["HIV infection (therapeutic vaccine in combination with antiretroviral therapy)"],"catalyst":""},{"name":"Tat protein","genericName":"Tat protein","slug":"tat-protein","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_2":1},"enrichmentLevel":2,"visitCount":13,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}